PRESS RELEASE published on 06/08/2026 at 15:13, 3 months 25 days ago Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT AI Software Guerbet Intrasense DUOnco™ Pancreas PMDA Certification
BRIEF published on 02/05/2026 at 15:34, 7 months 26 days ago Intrasense Revenue Rises 43% in 2025 Order Intake Intrasense Revenue Myrian® Sales AI-enhanced Imaging CE Markings
BRIEF published on 02/05/2026 at 15:31, 7 months 26 days ago Intrasense: Revenue growth of 43% by 2025 Intrasense Myrian® Revenue 2025 AI Medical Imaging Growth In Europe
PRESS RELEASE published on 02/05/2026 at 15:29, 7 months 26 days ago Annual revenue for 2025 up 43% to €3.2 million, in line with annual targets Intrasense reports 43% revenue increase to €3.2 million in 2025, meeting targets. Strong international sales for Myrian®. Innovation strategy with certifications Revenue Increase Certifications Financial Targets Intrasense Myrian
BRIEF published on 12/18/2025 at 18:03, 9 months 16 days ago Intrasense: Confirmation of 2025 Objectives and Strategic Adjustment Innovation Medical Imaging Intrasense Geographic Expansion 2025 Goals
PRESS RELEASE published on 08/13/2025 at 16:03, 1 year 1 month ago INTRASENSE : DUOnco™ Pancreas CE marking: a key innovation for the early detection of pancreactic cancer using AI Intrasense obtains CE marking under MDR for DUOnco™ Pancreas, an AI solution enhancing early detection of pancreatic cancer. CEO Alexandre Salvador highlights the innovation's importance in clinical practice and patient care AI Pancreatic Cancer CE Marking Intrasense DUOnco Pancreas
BRIEF published on 08/13/2025 at 15:59, 1 year 1 month ago Intrasense Obtains CE Certification for DUOnco™ Pancreas, a Breakthrough in Oncology Artificial Intelligence Oncology CE Certification Intrasense DUOnco™ Pancreas
BRIEF published on 07/28/2025 at 10:40, 1 year 2 months ago Half-Yearly Review of the Intrasense Liquidity Contract Liquidity Contract Actions Stock Market Transactions FASD Intrasense
BRIEF published on 06/06/2025 at 15:12, 1 year 3 months ago Intrasense Expands AI Solutions in Oncological Imaging Intrasense AI Imaging Oncology Solutions Myrian® DUOnco™
PRESS RELEASE published on 06/06/2025 at 15:07, 1 year 3 months ago Activity Update: structured offering of AI Solutions in oncological imaging and initial successful deployments Intrasense provides structured AI solutions for oncological imaging, incl. Myrian®, DUOnco™, and Liflow®. Successful deployments & collaborations enhance patient care AI Solutions Medical Imaging Collaborations Intrasense Oncological Imaging
Published on 10/02/2026 at 13:50, 1 day 13 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 14 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 14 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 11 hours 42 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 3 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 7 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 7 hours ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 9 hours ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 1 day 9 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/01/2026 at 19:00, 2 days 8 hours ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 8 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 9 hours ago Covivio - Information on total number of voting rights and share capital